Comparing Profound Medical (NASDAQ:PROF) and Tenon Medical (NASDAQ:TNON)

Profound Medical (NASDAQ:PROF) and Tenon Medical (NASDAQ:TNON) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, risk and valuation.

Analyst Recommendations

This is a summary of recent ratings and target prices for Profound Medical and Tenon Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Profound Medical	1	0	1	1	2.67
Tenon Medical	1	0	1	0	2.00

Profound Medical currently has a consensus target price of $11.50, suggesting a potential upside of 99.65%. Given Profound Medical’s stronger consensus rating and higher possible upside, analysts plainly believe Profound Medical is more favorable than Tenon Medical.

Profitability

This table compares Profound Medical and Tenon Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Profound Medical	-171.57%	-63.03%	-51.24%
Tenon Medical	-257.85%	-907.60%	-124.84%

Volatility and Risk

Profound Medical has a beta of 0.72, suggesting that its share price is 28% less volatile than the S&P 500. Comparatively, Tenon Medical has a beta of 1.36, suggesting that its share price is 36% more volatile than the S&P 500.

Insider & Institutional Ownership

47.9% of Profound Medical shares are owned by institutional investors. Comparatively, 22.7% of Tenon Medical shares are owned by institutional investors. 1.5% of Profound Medical shares are owned by company insiders. Comparatively, 17.7% of Tenon Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Profound Medical and Tenon Medical”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Profound Medical	$16.10 million	13.07	-$42.57 million	($0.98)	-5.88
Tenon Medical	$3.94 million	0.53	-$12.56 million	($44.87)	-0.07

Tenon Medical has lower revenue, but higher earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

Summary

Profound Medical beats Tenon Medical on 10 of the 14 factors compared between the two stocks.

About Profound Medical

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

About Tenon Medical

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.